If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration
What happens is, you lose weight fast, and your body kind of freaks out
The supplement contains BHB ketones, which are commonly included to help support energy levels, reduce cravings, and encourage fat utilization
Aim for 2 to 3 liters of fluid daily as a baseline, with additional intake during periods of GI side effects, exercise, or hot weather
Third-party tested, standardized to 97% berberine HCl is what youre looking for on the label
If you are cash-pay, the lowest-cost compounded option in the PlexusDx catalog is the Microdose GLP-1 Protocol at $129/mo flat all-inclusive of clinician consultation, compounded medication, and shipping